Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with over $350 million under management. We seek transformative, cutting-edge life sciences technologies at all development stages. Our portfolio comprises over 40 companies that develop breakthrough solutions to substantial unmet needs. Pontifax invests in breakthrough innovation regardless of therapeutic area or development stage. We establish our own companies as well as partner with existing managements to nurture start-ups to maturity. Pontifax takes a hands-on approach in its portfolio management and is deeply involved in charting the course of each company.